Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraemar Shipping Regulatory News (BMS)

Share Price Information for Braemar Shipping (BMS)

Share Price is delayed by 15 minutes
Get Live Data
247.00    2.50 (1.06%)
Bid:
235.00
Ask:
240.00
Spread: 5.00 (2.128%)
Market Cap: £79.01m
BMS Live PriceLast checked at - London Stock Exchange

Intraday Braemar Shipping Share Chart

HY26 Trading Update

25 Sep 2025 07:00

RNS Number : 7085A
Braemar PLC
25 September 2025
Β 

Β 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU NO. 596/2014) WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

25 September 2025

BRAEMAR PLC

("Braemar", "the Company" and together with its subsidiaries the "Group")

Β 

HY26 TRADING UPDATE

Β 

Continued delivery against challenging H1 market backdrop

FY26 board expectations unchanged, with H2 market conditions improving

Β 

Braemar Plc (LSE: BMS), a leading provider of expert investment, chartering and risk management advice to the shipping and energy markets, announces a trading update for the six months ending 31 August 2025 ("HY26").

Trading Update

Β· Diversified business model partially offsetting weaker H1 chartering rates

Β· H2 chartering rates improving and sale and purchase activity increasing

Β· Good progress against strategic targets set in May 2025

Β· Order book remains strong and board's FY26 expectations unchanged

The Group continued to benefit from its balanced and diversified business model in HY26, with a good performance in both the Investment Advisory and Risk Advisory divisions partially offsetting the financial impact of lower chartering rates, geopolitical volatility and a much weaker US dollar.

HY26 revenue is expected to be in the region of Β£63.8m (HY25: Β£76.0m), with underlying profit (before acquisition-related expenditure) of c.Β£5.5m (HY25: Β£8.0m).

Following the completion of a Β£2.0m share buyback and in line with the Group's usual working capital cycle, net debt at 31 August 2025 was Β£5.6m (FY25: net debt Β£2.5m).

Strategic Progress

Since setting out our future ambitions through the Group's Strategic Framework on 29 May 2025, progress continues to be made in the delivery of the Group's FY30 targets and shorter term FY26 operational objectives.

Against the FY26 operational objectives, a number of senior hires have been made, a new office in South Africa has been opened, efficiencies are being delivered in Tanker operations, and the Group continues to evaluate potential acquisitions.

Outlook

The Group's forward order book at the end of August 2025 remained strong at $73.8m (HY25: $80.9m) and has strengthened further in September 2025. We have also seen an improvement in chartering rates at the start of the second half of the year.

Consequently, the board's expectations for the full year remain unchanged, with the Group's performance expected to be second half weighted in line with most previous years.

The board remains confident in the longer-term outlook for the Group and delivering on its FY30 objectives.

Commenting, James Gundy, Group CEO of Braemar said:

"We have made good progress with our strategic priorities and continue to benefit from the resilience of our diversified business model. Our solid H1 performance was achieved despite a challenging trading environment, ongoing weaker chartering rates and competition for talent across the industry.

Looking ahead, the market fundamentals continue to be robust, and the Group remains in a strong position to take advantage of opportunities. Our forward order book is strong and improving, and charter rates, particularly in Tankers, have increased since the start of H2, underpinning our confidence in the full year outlook. We remain focused on delivering our long-term strategic plan."

Β 

Notice of Results

The Group expects to announce its HY26 results by mid-November 2025.

1. Underlying results measures above are before specific items

2. The total forward order book covers revenue that will be earned in future periods up until 2039

3. Company compiled consensus prior to the release of this announcement: revenue Β£133.8m (Β£131.1m - Β£139.4m); underlying operating profit (before acquisition-related expenditure) Β£13.5m (Β£13.0m - Β£13.8m)

Β 

Enquiries:

Braemar Plc

Tel: +44 (0)20 3142 4100

James Gundy, Group Chief Executive Officer

Grant Foley, Group Chief Financial Officer

Rebecca-Joy Wekwete, Company Secretary

Houston

Tel: +44 (0)20 4529 0549

Kate Hoare / Charlie Barker / Ben Robinson

Braemar@houston.co.uk

Canaccord Genuity

Tel: +44 (0)20 7523 8000

Adam James / Harry Rees

Β 

About Braemar Plc

Braemar provides expert advice in shipping investment, chartering, and risk management to enable its clients to secure sustainable returns and mitigate risk in the volatile world of shipping. Our experienced brokers work in tandem with specialist professionals to form teams tailored to our customers' needs, and provide an integrated service supported by a collaborative culture.

Braemar joined the Official List of the London Stock Exchange in November 1997 and trades under the symbol BMS.

For more information, including our investor presentation, visitΒ www.braemar.comΒ and follow Braemar onΒ LinkedIn.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTLIMFTMTITBIA
Date   Source Headline
26th Aug 20217:00 amRNSAGM Trading Update
18th Aug 20217:00 amRNSDirector/PDMR Shareholding
12th Aug 20217:00 amRNSBlock listing Interim Review
3rd Aug 20215:05 pmRNSAnnual Report and Notice of AGM
2nd Aug 20217:00 amRNSTotal Voting Rights
23rd Jul 20216:12 pmRNSHolding(s) in Company
22nd Jul 20217:00 amRNSBoard Changes – Supporting Further Growth
16th Jul 202112:02 pmRNSHolding(s) in Company
30th Jun 20217:00 amRNSTotal Voting Rights
22nd Jun 20212:10 pmRNSIssue of Shares to Employee Share Ownership Plan
21st Jun 20217:00 amRNSChange of AGM Date and Dividend Timetable
18th Jun 20219:32 amRNSUpdate on the sale of Wavespec
17th Jun 20214:13 pmRNSDirector / PDMR Shareholding
11th Jun 20215:07 pmRNSDirector/PDMR Shareholding
9th Jun 20217:00 amRNSHolding(s) in Company
7th Jun 20214:00 pmRNSHolding(s) in Company
4th Jun 20215:25 pmRNSHolding(s) in Company
4th Jun 20217:00 amRNSDirector/PDMR Shareholding
3rd Jun 20217:01 amRNSBraemar Naves Payment Rescheduling
3rd Jun 20217:00 amRNSPreliminary Results
20th May 20217:00 amRNSSale of AqualisBraemar Shares
19th May 20217:00 amRNSNotice of Preliminary Results
30th Apr 20217:00 amRNSTotal Voting Rights
7th Apr 20217:00 amRNSBoard Change
1st Apr 20217:00 amRNSDisposal of Wavespec
9th Mar 20217:00 amRNSTrading and Strategic Update and Board Change
16th Feb 20219:00 amRNSNotice of Trading Update & Capital Markets Event
12th Feb 20217:00 amRNSBlock listing Interim Review
28th Jan 20217:00 amRNSCompletion of AqualisBraemar Share Sale
27th Jan 20214:16 pmRNSPotential Sale of AqualisBraemar LOC ASA Shares
23rd Nov 202010:22 amRNSAqualisBraemar Acquisition of LOC Group
13th Nov 20207:00 amRNSDirector/PDMR Shareholding
11th Nov 20204:21 pmRNSInterim Results – Updated
11th Nov 20207:01 amRNSAppointment of Group Chief Executive Officer
11th Nov 20207:00 amRNSInterim Results
10th Nov 20207:00 amRNSNew Partnership with V.Ships Leisure
3rd Nov 20202:47 pmRNSStrategic Investment
2nd Nov 20203:00 pmRNSAqualisBraemar Q3-2020 Results
2nd Nov 20207:00 amRNSNotice of Interim Results
23rd Oct 202012:40 pmRNSHolding(s) in Company
14th Oct 20209:12 amRNSDirector/PDMR Shareholding
30th Sep 20202:01 pmRNSTotal Voting Rights
19th Aug 20205:02 pmRNSResult of AGM
19th Aug 20201:50 pmRNSAGM Trading Update
18th Aug 20209:01 amRNSDirector/PDMR Shareholding
14th Aug 20207:00 amRNSBlock listing Interim Review
29th Jul 20201:42 pmRNSDirector/PDMR Shareholding
20th Jul 20206:06 pmRNSAnnual Report and Notice of AGM
14th Jul 20207:00 amRNSHolding(s) in Company
13th Jul 20205:13 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.